Arbor Rapha Capital Bioholdings Corp. I (ARCKU) Company Bio
Arbor Rapha Capital Bioholdings Corp. I intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.
Arbor Rapha Capital Bioholdings Corp. I (the "Company") (NASDAQ: ARCKU) announced today the closing of its initial public offering of 17,250,000 units at $10.00 per unit, including 2,250,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The units are listed on The Nasdaq Global Market ("Nasdaq") and began trading under the ticker symbol "ARCKU" on October 29, 2021. Each unit consists of one share of Class A common stock and one-third of one red